Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers - Drug Trials For Money - Paid Clinical Trials

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Conditions:   Lymphoma, Non-Hodgkin;   B-cell Acute Lymphoblastic Leukemia;   Large B-cell Lymphoma;   Mantle Cell Lymphoma;   Indolent Lymphoma;   Waldenstrom Macroglobulinemia;   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Aggressive Lymphoma;   Large-cell Lymphoma
Intervention:   Biological: NKX019
Sponsor:   Nkarta Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 26, 2021 / by / in
Comments